Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
GRCE
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +22.9%
GRCE
Grace Therapeutics, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
grace
therapeutics
nimodipine
trial
strive
phase
2026
asah
results
announced
formulation
annual
oral
announces
accepted
presentation
injectable
aneurysmal
subarachnoid
hemorrhage